Decipher Biosciences Inc.
Genomic Profiling for Bladder Cancer
Decipher Bladder is the only genomic subtyping tool available to physicians in the United States treating patients with locally advanced bladder cancer.
Most popular related searches
bladder cancer
invasive bladder cancer
genomics
muscle invasive
genomic profile
genomic profiling
cancer genetic
bladder cancer patient
surgery
chemotherapy
- Highly Accurate : in classifying bladder tumors into four molecular subtypes
- Comprehensive : genome-wide assay of 46,000 genes
- Innovative : model derived from the Cancer Genome Atlas project
Decipher Bladder accurately classifies the molecular subtype of muscle-invasive bladder cancer and informs which patients may benefit from neoadjuvant chemotherapy (NAC) prior to radical cystectomy.
- Indicated for:
- Men and women considering NAC prior to surgery
- Predictive of:
- Survival benefit from NAC by molecular subtyping
- Recommended by:
- Luminal
- Luminal Infiltrated
- Basal
- Basal Claudin-Low